The company's worse-than-expected Q3 results and an accounting error have negatively impacted investor confidence, leading to a drop in the stock price. The sale of its reinsurance business, while potentially beneficial in the long term, may also contribute to short-term uncertainty. Additionally, the downgrades and lowered price targets by analysts further exacerbate the negative sentiment towards the stock.